Thursday, April, 18, 2019 08:16:38

Category: Biotechnology

Voluntis & AbbVie team up to develop companion digital therapeutics

Voluntis, a company specializing in digital therapeutics, has reportedly announced that it has formed a collaboration with research-based global biopharmaceutical company AbbVie, in order to improve patient care coordination in immunology through innovative digital therapeutic software. As per trusted sources, the companies will collectively leverage …

Aduro Biotech & Lilly to collaborate for R&D of novel immunotherapies

The U.S.-based global pharmaceutical firm Eli Lilly & Company, and California-based immunotherapy company, Aduro Biotech, are currently in the news for announcing a research collaboration, as well as an exclusive license deal, for the cGAS-STING pathway inhibitor program that would develop new immunotherapies for inflammatory …

Distributed Bio forms multi-target partnership with Good Therapeutics

Distributed Bio, which a global leader in computational optimization of fully human monoclonal antibody libraries, has recently made an announcement confirming a multi-target collaboration with Seattle-based Good Therapeutics Inc. According to BioSpace, Distributed Bio, under the partnership, would be using its SuperHuman antibody library platform …

MIT Engineers claim repurposed wasp venom to cure lung disease

Engineers at the renowned MIT Institute claim to have developed new antimicrobial peptides that fight bacteria causing respiratory diseases and other infections. These antimicrobial peptides are based on a naturally occurring peptide that is produced by the South American wasp. Incidentally, the venom of bees …

Aimmune Therapeutics closes $98M Investment by Nestlé Health Science

Aimmune Therapeutics Inc., a California-based clinical-stage biopharmaceutical company, has reportedly announced that it has closed the $98 million equity investment by Nestlé Health Science. Reports cite, Nestlé Health Science bought about 3,237,529 newly issued shares of the Brisbane, California-headquartered Aimmune Therapeutics’ common stock, at a …